These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 25638292)

  • 41. Characterization of Beta-lactamases in Faecal Enterobacteriaceae Recovered from Healthy Humans in Spain: Focusing on AmpC Polymorphisms.
    Porres-Osante N; Sáenz Y; Somalo S; Torres C
    Microb Ecol; 2015 Jul; 70(1):132-40. PubMed ID: 25501887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic contexts related to the diffusion of plasmid-mediated CTX-M-55 extended-spectrum beta-lactamase isolated from Enterobacteriaceae in China.
    Hu X; Gou J; Guo X; Cao Z; Li Y; Jiao H; He X; Ren Y; Tian F
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):12. PubMed ID: 29571292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae].
    Wang QT; Liu YM; Wang H; Sun HL; Chen MJ; Du XL
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):487-90. PubMed ID: 15312399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL)--and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina.
    Uzunović S; Bedenić B; Budimir A; Kamberović F; Ibrahimagić A; Delić-Bikić S; Sivec S; Meštrović T; Varda Brkić D; Rijnders MI; Stobberingh EE
    Wien Klin Wochenschr; 2014 Dec; 126(23-24):747-56. PubMed ID: 25193483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.
    Munday CJ; Whitehead GM; Todd NJ; Campbell M; Hawkey PM
    J Antimicrob Chemother; 2004 Sep; 54(3):628-33. PubMed ID: 15294889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of IncHI2 plasmids harbouring blaVIM-1, blaCTX-M-9, aac(6')-Ib and qnrA genes in the spread of multiresistant Enterobacter cloacae and Klebsiella pneumoniae strains in different units at Hospital Vall d'Hebron, Barcelona, Spain.
    Coelho A; Piedra-Carrasco N; Bartolomé R; Quintero-Zarate JN; Larrosa N; Cornejo-Sánchez T; Prats G; Garcillán-Barcia MP; de la Cruz F; González-Lopéz JJ
    Int J Antimicrob Agents; 2012 Jun; 39(6):514-7. PubMed ID: 22481058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
    Lee KK; Kim ST; Hong KS; Huh HJ; Chae SL
    Korean J Lab Med; 2008 Jun; 28(3):185-90. PubMed ID: 18594169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico.
    Garza-González E; Mendoza Ibarra SI; Llaca-Díaz JM; Gonzalez GM
    J Med Microbiol; 2011 Jan; 60(Pt 1):84-90. PubMed ID: 20930052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence study of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals.
    Abdalhamid B; Albunayan S; Shaikh A; Elhadi N; Aljindan R
    J Med Microbiol; 2017 Sep; 66(9):1286-1290. PubMed ID: 28820112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance.
    Hansen DS; Schumacher H; Hansen F; Stegger M; Hertz FB; Schønning K; Justesen US; Frimodt-Møller N;
    Scand J Infect Dis; 2012 Mar; 44(3):174-81. PubMed ID: 22364227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.
    Chia JH; Chu C; Su LH; Chiu CH; Kuo AJ; Sun CF; Wu TL
    J Clin Microbiol; 2005 Sep; 43(9):4486-91. PubMed ID: 16145096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
    Kiratisin P; Apisarnthanarak A; Laesripa C; Saifon P
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2818-24. PubMed ID: 18505851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Identification and expression of blaCTX-M-14 and blaCTX-M-24].
    Xiong ZZ; Zhu DM; Wang F; Zhang YY
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1454-9. PubMed ID: 15500745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
    Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
    J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
    Woodford N; Kaufmann ME; Karisik E; Hartley JW
    J Antimicrob Chemother; 2007 Jan; 59(1):106-9. PubMed ID: 17090553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
    Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK
    Int J Antimicrob Agents; 2018 Aug; 52(2):287-292. PubMed ID: 29654893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization of extended-spectrum-β-lactamase-producing and plasmid-mediated AmpC β-lactamase-producing Escherichia coli isolated from stray dogs in South Korea.
    Tamang MD; Nam HM; Jang GC; Kim SR; Chae MH; Jung SC; Byun JW; Park YH; Lim SK
    Antimicrob Agents Chemother; 2012 May; 56(5):2705-12. PubMed ID: 22354297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004.
    Song W; Kim JS; Kim HS; Yong D; Jeong SH; Park MJ; Lee KM
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):219-24. PubMed ID: 16545935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.